Cardiologists suggest patient-centered approach to replacing implantable cardioverter-defibrillators

January 25, 2012

More than 100,000 implantable cardioverter-defibrillators (ICDs) are implanted in the United States annually, fully a quarter of those are generator replacements simply because the battery is depleted. But are all those replacements necessary and should they actually be performed?

Writing in the Jan. 26 issue of the , doctors at the CardioVascular Institute at Beth Israel Deaconess Medical Center suggest the answer is surely no.

Similar to a pacemaker, an ICD is implanted in the chest with a wire running to the heart of patients at risk for . The device delivers a shock of electricity to the heart when it detects an abnormal and potentially life threatening heart rhythm.

"Though ICDs are lifesaving for some patients, evaluation of the clinical and ethical aspects of ICD replacement is long overdue," writes lead author Daniel B. Kramer, MD, a Cardiac Electrophysiology Fellow at BIDMC and Clinical Fellow in Medicine at Harvard Medical School, who believes patients and doctors must move beyond the view that this type of therapy as a lifelong treatment.

"Some patients may elect to keep these devices for the rest of their lives," says Kramer. "But for others, the risks associated with replacing the device may outweigh any expected benefit. We really need to make decisions on an individual basis."

Kramer suggests that patients be assessed carefully before replacement, just as they were when the ICD was initially implanted.

Patient experiences with the device should also be factored in, such as inappropriate shocks, the patient's value system and personal preferences for end of life care. "A more concrete expression of a patient's wishes might emerge through an advance directive." The medical system itself also plays a significant role in clouding decisions around ICD replacement.

"There are often several doctors and several specialties consulting on one person's care," says Kramer, . "with ambiguity about who is ultimately responsible. Who makes the decision to avoid the possibly unnecessary and certainly very costly procedure?" he asks, adding that the current fee-for-service system offers little to no incentive for doctors to decline the procedure.

More challenging for doctors, may be the moral objection from doctors and patients to stopping a potentially life-saving or life-prolonging device.

"Indeed, some patients or physicians might consider non-replacement equivalent to either physician-assisted suicide or euthanasia, despite consensus statements that clearly reject this view."

"What we really need are clinical trials focusing on ICD replacement," says Kramer. "Doctors and patients need data evaluating outcomes to better inform the decision making process."

While awaiting studies that can help inform evidence-based guidelines, Kramer suggests who implant ICDs should take the lead in educating "primary care physicians, general cardiologists, and other specialists regarding the appropriateness of ICD replacement for individual patients."

And conversations with patients and family members about down-the-line replacement should start early, ideally at the time of the initial placement.

" should not find themselves committed to a lifelong therapy or trapped by misconceptions about clinical, ethical, and legal aspects of choosing not to replace a device."

Explore further: Gene variant may predict sudden cardiac death risk for blacks

Related Stories

Gene variant may predict sudden cardiac death risk for blacks

May 11, 2011
(Medical Xpress) -- Researchers at Duke University Medical Center have pinpointed a common gene variant in blacks that may be associated with the development of life-threatening heart arrhythmias. The finding may help determine ...

Remote ICD monitoring a 'safe alternative' to conventional follow up

August 29, 2011
Device management using a home monitoring system with daily telemetry in patients with ICDs (implantable cardioverter defibrilators) is a safe alternative to conventional monitoring and could decrease the number of inappropriate ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.